2024-05-13 11:25:02 ET
Exagen, Inc. (XGN)
Q1 2024 Earnings Conference Call
May 13, 2024 08:30 AM ET
Company Participants
Ryan Douglas - Investor Relations
John Aballi - President and Chief Executive Officer
Kamal Adawi - Chief Financial Officer
Conference Call Participants
Mark Massaro - BTIG
Kyle Mikson - Canaccord Genuity
Dan Brennan - TD Cowen
Presentation
Operator
Greetings, welcome to Exagen, Inc. First Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.
I will now turn the call over to Ryan Douglas with Investor Relations. Ryan, you may now begin.
Ryan Douglas
Good morning and thank you for joining us. Earlier today, Exagen, Inc. released financial results for the quarter ended March 31, 2024. The release is currently available on the company's website at www.exagen.com. John Aballi, President and Chief Executive Officer; and Kamal Adawi, Chief Financial Officer will host this morning's call.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
Exagen, Inc. (XGN) Q1 2024 Earnings Call Transcript